Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 220 citing articles:

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 204
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D’Agnillo, Kathie‐Anne Walters, Yongli Xiao, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 197
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
Ali A. Rabaan, Raghavendra Tirupathi, Anupam Sule, et al.
Diagnostics (2021) Vol. 11, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 193
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 169
The relationship between COVID‐19 viral load and disease severity: A systematic review
Omid Dadras, Amir Masoud Afsahi, Zahra Pashaei, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 147
COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 94
COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 48
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 101
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects
Annamaria Russo, Ester Tellone, Davide Barreca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2171-2171
Open Access | Times Cited: 65
Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 2, pp. 154-167
Closed Access | Times Cited: 63
Clinical trials on the pharmacological treatment of long COVID: A systematic review
Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 63
Plant-Based Phytochemical Screening by Targeting Main Protease of SARS-CoV-2 to Design Effective Potent Inhibitors
Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, et al.
Biology (2021) Vol. 10, Iss. 7, pp. 589-589
Open Access | Times Cited: 58
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 40
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 34
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
Amit Dey, K. Vaishak, Dikshita Deka, et al.
Infection (2023) Vol. 51, Iss. 6, pp. 1603-1618
Open Access | Times Cited: 24
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 51
TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease
А. А. Савченко, Е. П. Тихонова, Igor Kudryavtsev, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 646-646
Open Access | Times Cited: 36
Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis
Saad Alhumaid, Ali A. Rabaan, Kuldeep Dhama, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1289-1289
Open Access | Times Cited: 31
Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29
Ibuprofen, other NSAIDs and COVID-19: a narrative review
William Laughey, Imran Lodhi, Graham Pennick, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2147-2159
Open Access | Times Cited: 17
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients
Ivan Papić, Petra Bistrović, Tomislav Čikara, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, et al.
European journal of medical research (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 39
Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients
Zainab Mahmood, Hula Y. Fadhil, Thaer Ali Hussein, et al.
Meta Gene (2022) Vol. 31, pp. 101014-101014
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top